Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Plasmodium falciparum | 1 | 2019 | 337 | 0.59 | Why? |
| Bayes Theorem | 3 | 2021 | 3237 | 0.52 | Why? |
| Faculty | 1 | 2017 | 406 | 0.50 | Why? |
| Publications | 1 | 2017 | 463 | 0.47 | Why? |
| Health Priorities | 1 | 2021 | 959 | 0.47 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.41 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.34 | Why? |
| Publishing | 1 | 2017 | 990 | 0.34 | Why? |
| Research Personnel | 1 | 2017 | 1037 | 0.33 | Why? |
| Mass Screening | 3 | 2021 | 8005 | 0.32 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.30 | Why? |
| Seroepidemiologic Studies | 5 | 2021 | 10017 | 0.25 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.24 | Why? |
| Calibration | 1 | 2021 | 307 | 0.20 | Why? |
| Uncertainty | 2 | 2021 | 1888 | 0.19 | Why? |
| Models, Theoretical | 3 | 2021 | 6659 | 0.17 | Why? |
| Genetic Fitness | 1 | 2019 | 339 | 0.17 | Why? |
| Models, Genetic | 1 | 2019 | 434 | 0.17 | Why? |
| Stochastic Processes | 1 | 2019 | 369 | 0.17 | Why? |
| Off-Label Use | 1 | 2021 | 553 | 0.16 | Why? |
| Narration | 1 | 2017 | 143 | 0.16 | Why? |
| Emergency Responders | 1 | 2021 | 479 | 0.15 | Why? |
| Career Mobility | 1 | 2017 | 224 | 0.14 | Why? |
| Transportation | 1 | 2020 | 691 | 0.13 | Why? |
| Efficiency | 1 | 2017 | 420 | 0.13 | Why? |
| Population Density | 1 | 2019 | 694 | 0.13 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.12 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.12 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.12 | Why? |
| Cost-Benefit Analysis | 1 | 2021 | 2259 | 0.11 | Why? |
| Epidemics | 2 | 2021 | 6407 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.10 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.07 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.06 | Why? |
| Child | 3 | 2021 | 70012 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.06 | Why? |
| Humans | 13 | 2021 | 930598 | 0.06 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.06 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.06 | Why? |
| Infant | 2 | 2021 | 30274 | 0.05 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.05 | Why? |
| Colorado | 1 | 2021 | 434 | 0.05 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.05 | Why? |
| Genetics, Population | 1 | 2019 | 162 | 0.05 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Biological Evolution | 1 | 2021 | 641 | 0.04 | Why? |
| Aged | 2 | 2021 | 215776 | 0.03 | Why? |
| Pakistan | 1 | 2021 | 2302 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Urban Population | 1 | 2021 | 2000 | 0.03 | Why? |
| Pregnant Women | 1 | 2020 | 2535 | 0.02 | Why? |
| New York City | 1 | 2020 | 7432 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.01 | Why? |
| Female | 3 | 2021 | 380317 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Larremore's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(79)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(73)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_